Full Day Care to Women Health

Abstract

Objective: To report the profile of the users participating of an extension project. Method: This is a quantitative, descriptive and documentary study. Results: The action had as participants the nursing academics of the Federal Fluminense University/UFF/PURO and conducted in five Basic Unit Health chosen to cover most of the population in the city of Rio das Ostras/RJ. Were performed cytopathological exams, mammograms request and health education to 462 users. It appears that the involved population found in some situations of vulnerability in which women subjected. Conclusion: This activity was of great significance for the professional training of nursing students, providing them, opportunities to participate in the health activities, facilitating the sedimentation of the theoretical knowledge.

Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis

“…The fibroblast cell line used for the test was L929, cultured at 37 ± 0.5 °C, containing DMEM with 10% fetal bovine serum (FBS) in an atmosphere with 5% CO 2 . A 1 mL cell suspension (1 × 10 6 cell/mL) in 10 mL of culture medium was prepared in a 75 cm 2 Corning culture flask and incubated until reaching 75−80%. Subsequently, a 2 × 10 5 cell/mL cell suspension was prepared, and 4 mL of this suspension was pipetted into a 6-well plate (Costar) in DMEM with 5% FBS.…”

“…1 The main clinical signs of VVC include vaginal discharge, irritation, and itching, which greatly impair the quality of life of women worldwide; nevertheless, VVC continues to have a high incidence and is responsible for affecting approximately 75% of all women at least once in their life, with 50% of them relapsing. 2 The morphological flexibility of Candida albicans is the determining factor for its high virulence, and it is fundamental for its vaginal infection pathogenesis. This makes it difficult to treat VVC with conventional therapies, such as ointments and creams which cause discomfort in patients and are easily removed from the vaginal region, compromising their effectiveness.…”

“…The main clinical signs of VVC include vaginal discharge, irritation, and itching, which greatly impair the quality of life of women worldwide; nevertheless, VVC continues to have a high incidence and is responsible for affecting approximately 75% of all women at least once in their life, with 50% of them relapsing. − …”